AMENDMENT TO CONVERTIBLE PROMISSORY NOTE AND WARRANTConvertible Promissory Note and Warrant Amendment • June 25th, 2014 • VistaGen Therapeutics, Inc. • Pharmaceutical preparations
This Amendment to Convertible Promissory Note and Warrant (this “Amendment”) is entered into and effective as of May 31, 2014 by and between VistaGen Therapeutics, Inc., a Nevada corporation (the “Company”), and the person whose signature appears on the signature page attached hereto (the “Investor”).
AMENDMENT NO. 2 TO CONVERTIBLE PROMISSORY NOTE AND AMENDMENT TO WARRANTSConvertible Promissory Note and Warrant Amendment • April 23rd, 2008 • Macrochem Corp • Pharmaceutical preparations • New York
This Amendment, dated as of March 26, 2008, (the “Amendment”) is by and between Virium Pharmaceuticals, Inc., a New York corporation (the “Company”) and Strategic Capital Resources, Inc (the “Holder”) and, among other things, amends certain provisions of (i) the Convertible Promissory Note in the original principal amount of $500,000, issued by the Company as Certificate No. PN-May-1 and dated as of May 30, 2007 (as amended pursuant to Amendment No. 1 (defined below), the “Note”), (ii) the Warrant (Warrant No. W-May07-1) representing the right to purchase up to 250,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) and issued to the Holder on May 30, 2007 (the “May 2007 Warrant”) and (iii) the Warrant (Warrant No. W-May07-2) representing the right to purchase up to 250,000 shares of Common Stock and issued to the Holder on November 30, 2007 (the “November 2007 Warrant”).
